KUBENA, Petr, Mattia ARRIGO, Jiří PAŘENICA, Etienne GAYAT, Malha SADOUNE, Eva GANOVSKÁ, Marie PAVLUŠOVÁ, Simona LITTNEROVÁ, Jindřich ŠPINAR and Alexandre MEBAZAA. Plasma Levels of Soluble CD146 Reflect the Severity of Pulmonary Congestion Better Than Brain Natriuretic Peptide in Acute Coronary Syndrome. Annals of laboratory medicine. Seoul: The Korean Society for Laboratory Medicine, 2016, vol. 36, No 4, p. 300-305. ISSN 2234-3806. Available from: https://dx.doi.org/10.3343/alm.2016.36.4.300.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Plasma Levels of Soluble CD146 Reflect the Severity of Pulmonary Congestion Better Than Brain Natriuretic Peptide in Acute Coronary Syndrome
Authors KUBENA, Petr (203 Czech Republic, belonging to the institution), Mattia ARRIGO (756 Switzerland), Jiří PAŘENICA (203 Czech Republic, guarantor, belonging to the institution), Etienne GAYAT (250 France), Malha SADOUNE (250 France), Eva GANOVSKÁ (703 Slovakia, belonging to the institution), Marie PAVLUŠOVÁ (203 Czech Republic, belonging to the institution), Simona LITTNEROVÁ (203 Czech Republic, belonging to the institution), Jindřich ŠPINAR (203 Czech Republic, belonging to the institution) and Alexandre MEBAZAA (250 France).
Edition Annals of laboratory medicine, Seoul, The Korean Society for Laboratory Medicine, 2016, 2234-3806.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher France
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.174
RIV identification code RIV/00216224:14110/16:00090321
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3343/alm.2016.36.4.300
UT WoS 000376049300002
Keywords in English Acute coronary syndrome; Myocardial infarction; Pulmonary congestion; Pulmonary edema; sCD146
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 4/8/2016 15:20.
Abstract
Background: Acute heart failure negatively affects short-term outcomes of patients with acute coronary syndrome (ACS). Therefore, reliable and non-invasive assessment of pulmonary congestion is needed to select patients requiring more intensive monitoring and therapy. Since plasma levels of natriuretic peptides are influenced by myocardial ischemia, they might not reliably reflect congestion in the context of ACS. The novel endothelial biomarker, soluble CD146 (sCD146), presents discriminative power for detecting the cardiac origin of acute dyspnea similar to that of natriuretic peptides and is associated with systemic congestion. We evaluated the performance of sCD146 for the assessment of pulmonary congestion in the early phase of ACS. Methods: One thousand twenty-one consecutive patients with ACS were prospectively enrolled. Plasma levels of sCD146, brain natriuretic peptide (BNP), and high-sensitive troponin T were measured within 24 hr after the onset of chest pain. Pulmonary congestion on chest radiography was determined and classified in three groups according to the degree of congestion. Results: Nine hundred twenty-seven patients with ACS were analyzed. Ninety-two (10%) patients showed signs of pulmonary edema on chest radiography. Plasma levels of sCD146 reflected the radiological severity of pulmonary congestion. Higher plasma levels of sCD146 were associated with the worse degree of pulmonary congestion. In contrast to BNP, sCD146 levels were not affected by the level of troponin T. Conclusions: The novel endothelial biomarker, sCD146, correlates with radiological severity of pulmonary congestion in the early phase of ACS and, in contrast to BNP, is not affected by the amount of myocardial cell necrosis.
PrintDisplayed: 6/6/2024 00:38